Medidata Solutions to Lead Discussions on Cloud-based Clinical Technology at 48th DIA Annual Meeting

NEW YORK–(BUSINESS WIRE)–Experts from Medidata Solutions (NASDAQ: MDSO) will be driving dialogue in nine conference sessions at the upcoming Drug Information Association’s (DIA) Annual Meeting, to be held June 24-28 in Philadelphia, Pa., and Medidata’s team will discuss current and future clinical research challenges and solutions in areas including protocol design, electronic health records integration and risk-based monitoring.

“We always look forward to the DIA Annual Meeting as a place to share our latest innovations, meet old friends and see what’s happening across the industry,” said Tarek Sherif, chairman and CEO of Medidata Solutions. “Attendees of Medidata-led sessions and visitors to our booth will be shown real-world examples of how leveraging the clinical cloud can help increase efficiencies while reducing cost and risk from clinical trial concept to conclusion.”

In addition to showcasing new product enhancements at booth #3101, Medidata experts will be leading the following sessions at this year’s Annual Meeting:

Connect with Medidata:

About Medidata Solutions Worldwide

Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.